Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1984 1
1985 1
1986 3
1987 1
1988 2
1990 1
1991 1
1992 1
1993 4
1994 2
1995 5
1996 5
1997 6
1998 4
1999 7
2000 19
2001 9
2002 19
2003 17
2004 18
2005 16
2006 30
2007 33
2008 49
2009 47
2010 74
2011 84
2012 70
2013 72
2014 112
2015 92
2016 101
2017 93
2018 154
2019 162
2020 203
2021 224
2022 227
2023 243
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

1,999 results

Results by year

Filters applied: . Clear all
Page 1
Etiological and epidemiological features of acute respiratory infections in China.
Li ZJ, Zhang HY, Ren LL, Lu QB, Ren X, Zhang CH, Wang YF, Lin SH, Zhang XA, Li J, Zhao SW, Yi ZG, Chen X, Yang ZS, Meng L, Wang XH, Liu YL, Wang X, Cui AL, Lai SJ, Jiang T, Yuan Y, Shi LS, Liu MY, Zhu YL, Zhang AR, Zhang ZJ, Yang Y, Ward MP, Feng LZ, Jing HQ, Huang LY, Xu WB, Chen Y, Wu JG, Yuan ZH, Li MF, Wang Y, Wang LP, Fang LQ, Liu W, Hay SI, Gao GF, Yang WZ; Chinese Centers for Disease Control and Prevention (CDC) Etiology of Respiratory Infection Surveillance Study Team. Li ZJ, et al. Among authors: jing hq. Nat Commun. 2021 Aug 18;12(1):5026. doi: 10.1038/s41467-021-25120-6. Nat Commun. 2021. PMID: 34408158 Free PMC article.
PD-L1/LAG-3 bispecific antibody enhances tumor-specific immunity.
Jiang H, Ni H, Zhang P, Guo X, Wu M, Shen H, Wang J, Wu W, Wu Z, Ding J, Tang R, Zhou S, Chen B, Yu M, Jing H, Liu J. Jiang H, et al. Among authors: jing h. Oncoimmunology. 2021 Jun 24;10(1):1943180. doi: 10.1080/2162402X.2021.1943180. eCollection 2021. Oncoimmunology. 2021. PMID: 34239776 Free PMC article.
Targeting glioblastoma signaling and metabolism with a re-purposed brain-penetrant drug.
Bi J, Khan A, Tang J, Armando AM, Wu S, Zhang W, Gimple RC, Reed A, Jing H, Koga T, Wong IT, Gu Y, Miki S, Yang H, Prager B, Curtis EJ, Wainwright DA, Furnari FB, Rich JN, Cloughesy TF, Kornblum HI, Quehenberger O, Rzhetsky A, Cravatt BF, Mischel PS. Bi J, et al. Among authors: jing h. Cell Rep. 2021 Nov 2;37(5):109957. doi: 10.1016/j.celrep.2021.109957. Cell Rep. 2021. PMID: 34731610 Free PMC article.
Phase II, Open-Label Study of Ciltacabtagene Autoleucel, an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor-T-Cell Therapy, in Chinese Patients With Relapsed/Refractory Multiple Myeloma (CARTIFAN-1).
Mi JQ, Zhao W, Jing H, Fu W, Hu J, Chen L, Zhang Y, Yao D, Chen D, Schecter JM, Yang F, Tian X, Sun H, Zhuang SH, Ren J, Fan X, Jin J, Niu T, Chen SJ. Mi JQ, et al. Among authors: jing h. J Clin Oncol. 2023 Feb 20;41(6):1275-1284. doi: 10.1200/JCO.22.00690. Epub 2022 Oct 21. J Clin Oncol. 2023. PMID: 36269898 Clinical Trial.
Medication therapy of high-dose methotrexate: An evidence-based practice guideline of the Division of Therapeutic Drug Monitoring, Chinese Pharmacological Society.
Song Z, Hu Y, Liu S, Wang G, Zhai S, Zhang X, Li Y, Du G, Shi Y, Chen Y, Dong M, Guo R, Guo W, Huang H, Huang X, Jing H, Ke X, Li G, Miao L, Niu X, Qiu F, Shen J, Tang J, Wang T, Wang X, Wang Z, Wu J, Zhan S, Zhang B, Zhang L, Zhang Y, Zhang W, Zhao L, Zhao L, Zhen J, Zheng H, Zhu Z, Jiang D, Huang Z, Tan Z, Lin Q, Zhao R. Song Z, et al. Among authors: jing h. Br J Clin Pharmacol. 2022 May;88(5):2456-2472. doi: 10.1111/bcp.15134. Epub 2022 Feb 8. Br J Clin Pharmacol. 2022. PMID: 34729817 Free article.
1,999 results